CN Stock MarketDetailed Quotes

688253 Innovita Biological Technology

Watchlist
  • 34.35
  • +0.33+0.97%
Market Closed Jul 26 15:00 CST
4.67BMarket Cap17.55P/E (TTM)

Innovita Biological Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
109.36%281.61M
7.03%478.02M
-10.34%278.43M
-10.49%223.58M
93.55%134.51M
36.62%446.62M
17.46%310.53M
15.06%249.79M
-46.12%69.5M
-68.48%326.91M
Operating revenue
109.36%281.61M
7.03%478.02M
-10.34%278.43M
-10.49%223.58M
93.55%134.51M
36.62%446.62M
17.46%310.53M
15.06%249.79M
-46.12%69.5M
-68.48%326.91M
Total operating cost
26.94%99.56M
-11.34%262.27M
-2.75%172.68M
-9.66%124.31M
47.68%78.43M
46.27%295.83M
20.31%177.55M
24.78%137.6M
6.28%53.11M
-44.93%202.25M
Operating cost
0.68%46.33M
-33.74%114.81M
-30.20%79.07M
-26.61%65.07M
92.03%46.02M
127.17%173.28M
89.44%113.29M
91.48%88.66M
-8.39%23.96M
-30.97%76.28M
Operating tax surcharges
51.12%1.53M
-64.16%3.21M
-65.95%2.18M
-53.13%1.63M
39.11%1.01M
204.74%8.95M
174.76%6.41M
85.00%3.48M
-32.61%727.84K
-63.97%2.94M
Operating expense
87.14%20.31M
15.72%58.18M
-0.48%32.63M
11.57%20.73M
20.16%10.85M
5.09%50.28M
-1.70%32.79M
-19.81%18.58M
-23.43%9.03M
-52.94%47.84M
Administration expense
10.68%10.82M
0.88%40.92M
20.32%32.71M
26.81%20.95M
37.05%9.77M
12.30%40.56M
-3.34%27.19M
-15.69%16.52M
-5.76%7.13M
-31.98%36.12M
Financial expense
-280.11%-1.41M
83.89%-7.96M
83.55%-8.32M
71.67%-6.73M
-42.92%784.5K
-720.50%-49.42M
-4,697.91%-50.6M
-824.06%-23.74M
148.53%1.37M
-76.88%7.96M
-Interest expense (Financial expense)
-37.86%36.19K
-51.25%199.59K
-30.91%160.86K
-33.63%112K
-38.28%58.24K
205.82%409.45K
103.10%232.83K
80.77%168.73K
28.11%94.37K
-23.77%133.88K
-Interest Income (Financial expense)
50.85%-1.34M
-5.41%-7.64M
-36.00%-6.48M
-287.41%-4.95M
-367.20%-2.72M
-259.68%-7.25M
-166.77%-4.76M
-8.14%-1.28M
-61.88%-582.18K
-184.55%-2.02M
Research and development
120.09%21.98M
-26.42%53.11M
-29.03%34.4M
-33.56%22.66M
-8.17%9.99M
132.00%72.18M
112.01%48.47M
112.52%34.11M
75.52%10.88M
-47.63%31.11M
Credit Impairment Loss
-5,927.37%-19.01M
32.51%-4.52M
60.85%-1.4M
55.50%-1.63M
260.62%326.15K
-2,026.49%-6.69M
-10,309.50%-3.57M
-11,307.40%-3.66M
-235.44%-203.06K
1,394.96%347.47K
Asset Impairment Loss
89.02%-378.93K
-6,695.09%-45.24M
-5,618.72%-26.23M
-9,305.58%-24.07M
-2,748.09%-3.45M
30.65%-665.79K
13.81%-458.74K
-144.08%-255.92K
116.11%130.37K
-89.46%-960.02K
Other net revenue
Fair value change income
148.15%4.86M
311.13%9.15M
1,565.53%4.59M
2,123.03%4.25M
579.85%1.96M
151.22%2.23M
-53.62%275.31K
-56.32%191K
29.58%288.3K
624.14%885.84K
Invest income
26.62%4.85M
248.36%16.93M
1,401.24%12.07M
305.30%6.43M
730.62%3.83M
208.66%4.86M
-46.58%803.89K
25.12%1.59M
-29.65%460.81K
-53.79%1.57M
-Including: Investment income associates
---1.06M
-0.24%-1.06M
----
---1.63M
----
---1.06M
----
----
----
----
Asset deal income
--22.09
-82.92%2.19K
----
----
----
--12.83K
--12.83K
--12.83K
--12.83K
----
Other revenue
-74.65%869.75K
-54.72%7.98M
-49.28%7.02M
-50.69%6.47M
-72.91%3.43M
32.69%17.63M
423.51%13.83M
428.63%13.12M
517.18%12.66M
607.35%13.29M
Operating profit
178.66%173.25M
18.97%200.05M
-29.25%101.8M
-26.36%90.71M
109.05%62.17M
20.30%168.16M
18.87%143.88M
11.04%123.18M
-63.42%29.74M
-79.28%139.79M
Add:Non operating Income
712.38%254.59K
97.36%290.19K
-4.78%88.66K
-47.82%45.22K
29.05%31.34K
189.73%147.04K
414.87%93.11K
564.07%86.66K
204.69%24.28K
3.99%50.75K
Less:Non operating expense
142,003.66%239.29K
-47.84%1.98M
-32.45%1.67M
-48.03%1.26M
-99.96%168.39
86.80%3.8M
140.70%2.48M
135.47%2.42M
-57.38%438.67K
574.74%2.03M
Total profit
178.54%173.26M
20.58%198.36M
-29.18%100.21M
-25.94%89.5M
112.11%62.2M
19.38%164.51M
17.89%141.5M
9.94%120.84M
-63.47%29.33M
-79.57%137.81M
Less:Income tax cost
224.14%27.18M
76.60%24.41M
-0.97%13.67M
-1.52%12.09M
182.14%8.38M
-21.66%13.82M
-9.28%13.81M
-15.31%12.27M
-73.64%2.97M
-82.81%17.65M
Net profit
171.44%146.09M
15.44%173.95M
-32.23%86.54M
-28.70%77.41M
104.21%53.82M
25.40%150.68M
21.83%127.69M
13.78%108.57M
-61.80%26.35M
-78.99%120.16M
Net profit from continuing operation
171.44%146.09M
15.44%173.95M
-32.23%86.54M
-28.70%77.41M
104.21%53.82M
25.40%150.68M
21.83%127.69M
13.78%108.57M
-61.80%26.35M
-78.99%120.16M
Less:Minority Profit
----
----
----
----
----
----
----
99.64%-335.53
99.66%-311.78
-125.74%-92.32K
Net profit of parent company owners
171.44%146.09M
15.44%173.95M
-32.23%86.54M
-28.70%77.41M
104.21%53.82M
25.31%150.68M
21.73%127.69M
13.67%108.57M
-61.85%26.35M
-78.96%120.25M
Earning per share
Basic earning per share
167.50%1.07
3.23%1.28
-35.35%0.64
-46.23%0.57
53.85%0.4
5.08%1.24
-3.88%0.99
12.77%1.06
-61.76%0.26
-79.55%1.18
Diluted earning per share
167.50%1.07
3.23%1.28
-35.35%0.64
-46.23%0.57
53.85%0.4
5.08%1.24
-3.88%0.99
12.77%1.06
-61.76%0.26
-79.55%1.18
Other composite income
63.23K
-1.02M
1.3M
1.44M
Other composite income of parent company owners
--63.23K
---1.02M
--1.3M
--1.44M
----
----
----
----
----
----
Total composite income
171.56%146.15M
14.76%172.92M
-31.21%87.84M
-27.37%78.85M
104.21%53.82M
25.40%150.68M
21.83%127.69M
13.78%108.57M
-61.80%26.35M
-78.99%120.16M
Total composite income of parent company owners
171.56%146.15M
14.76%172.92M
-31.21%87.84M
-27.37%78.85M
104.21%53.82M
25.31%150.68M
21.73%127.69M
13.67%108.57M
-61.85%26.35M
-78.96%120.25M
Total composite income of minority owners
----
----
----
----
----
----
----
99.64%-335.53
99.66%-311.78
-125.74%-92.32K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
--
--
--
--
--
Auditor
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 109.36%281.61M7.03%478.02M-10.34%278.43M-10.49%223.58M93.55%134.51M36.62%446.62M17.46%310.53M15.06%249.79M-46.12%69.5M-68.48%326.91M
Operating revenue 109.36%281.61M7.03%478.02M-10.34%278.43M-10.49%223.58M93.55%134.51M36.62%446.62M17.46%310.53M15.06%249.79M-46.12%69.5M-68.48%326.91M
Total operating cost 26.94%99.56M-11.34%262.27M-2.75%172.68M-9.66%124.31M47.68%78.43M46.27%295.83M20.31%177.55M24.78%137.6M6.28%53.11M-44.93%202.25M
Operating cost 0.68%46.33M-33.74%114.81M-30.20%79.07M-26.61%65.07M92.03%46.02M127.17%173.28M89.44%113.29M91.48%88.66M-8.39%23.96M-30.97%76.28M
Operating tax surcharges 51.12%1.53M-64.16%3.21M-65.95%2.18M-53.13%1.63M39.11%1.01M204.74%8.95M174.76%6.41M85.00%3.48M-32.61%727.84K-63.97%2.94M
Operating expense 87.14%20.31M15.72%58.18M-0.48%32.63M11.57%20.73M20.16%10.85M5.09%50.28M-1.70%32.79M-19.81%18.58M-23.43%9.03M-52.94%47.84M
Administration expense 10.68%10.82M0.88%40.92M20.32%32.71M26.81%20.95M37.05%9.77M12.30%40.56M-3.34%27.19M-15.69%16.52M-5.76%7.13M-31.98%36.12M
Financial expense -280.11%-1.41M83.89%-7.96M83.55%-8.32M71.67%-6.73M-42.92%784.5K-720.50%-49.42M-4,697.91%-50.6M-824.06%-23.74M148.53%1.37M-76.88%7.96M
-Interest expense (Financial expense) -37.86%36.19K-51.25%199.59K-30.91%160.86K-33.63%112K-38.28%58.24K205.82%409.45K103.10%232.83K80.77%168.73K28.11%94.37K-23.77%133.88K
-Interest Income (Financial expense) 50.85%-1.34M-5.41%-7.64M-36.00%-6.48M-287.41%-4.95M-367.20%-2.72M-259.68%-7.25M-166.77%-4.76M-8.14%-1.28M-61.88%-582.18K-184.55%-2.02M
Research and development 120.09%21.98M-26.42%53.11M-29.03%34.4M-33.56%22.66M-8.17%9.99M132.00%72.18M112.01%48.47M112.52%34.11M75.52%10.88M-47.63%31.11M
Credit Impairment Loss -5,927.37%-19.01M32.51%-4.52M60.85%-1.4M55.50%-1.63M260.62%326.15K-2,026.49%-6.69M-10,309.50%-3.57M-11,307.40%-3.66M-235.44%-203.06K1,394.96%347.47K
Asset Impairment Loss 89.02%-378.93K-6,695.09%-45.24M-5,618.72%-26.23M-9,305.58%-24.07M-2,748.09%-3.45M30.65%-665.79K13.81%-458.74K-144.08%-255.92K116.11%130.37K-89.46%-960.02K
Other net revenue
Fair value change income 148.15%4.86M311.13%9.15M1,565.53%4.59M2,123.03%4.25M579.85%1.96M151.22%2.23M-53.62%275.31K-56.32%191K29.58%288.3K624.14%885.84K
Invest income 26.62%4.85M248.36%16.93M1,401.24%12.07M305.30%6.43M730.62%3.83M208.66%4.86M-46.58%803.89K25.12%1.59M-29.65%460.81K-53.79%1.57M
-Including: Investment income associates ---1.06M-0.24%-1.06M-------1.63M-------1.06M----------------
Asset deal income --22.09-82.92%2.19K--------------12.83K--12.83K--12.83K--12.83K----
Other revenue -74.65%869.75K-54.72%7.98M-49.28%7.02M-50.69%6.47M-72.91%3.43M32.69%17.63M423.51%13.83M428.63%13.12M517.18%12.66M607.35%13.29M
Operating profit 178.66%173.25M18.97%200.05M-29.25%101.8M-26.36%90.71M109.05%62.17M20.30%168.16M18.87%143.88M11.04%123.18M-63.42%29.74M-79.28%139.79M
Add:Non operating Income 712.38%254.59K97.36%290.19K-4.78%88.66K-47.82%45.22K29.05%31.34K189.73%147.04K414.87%93.11K564.07%86.66K204.69%24.28K3.99%50.75K
Less:Non operating expense 142,003.66%239.29K-47.84%1.98M-32.45%1.67M-48.03%1.26M-99.96%168.3986.80%3.8M140.70%2.48M135.47%2.42M-57.38%438.67K574.74%2.03M
Total profit 178.54%173.26M20.58%198.36M-29.18%100.21M-25.94%89.5M112.11%62.2M19.38%164.51M17.89%141.5M9.94%120.84M-63.47%29.33M-79.57%137.81M
Less:Income tax cost 224.14%27.18M76.60%24.41M-0.97%13.67M-1.52%12.09M182.14%8.38M-21.66%13.82M-9.28%13.81M-15.31%12.27M-73.64%2.97M-82.81%17.65M
Net profit 171.44%146.09M15.44%173.95M-32.23%86.54M-28.70%77.41M104.21%53.82M25.40%150.68M21.83%127.69M13.78%108.57M-61.80%26.35M-78.99%120.16M
Net profit from continuing operation 171.44%146.09M15.44%173.95M-32.23%86.54M-28.70%77.41M104.21%53.82M25.40%150.68M21.83%127.69M13.78%108.57M-61.80%26.35M-78.99%120.16M
Less:Minority Profit ----------------------------99.64%-335.5399.66%-311.78-125.74%-92.32K
Net profit of parent company owners 171.44%146.09M15.44%173.95M-32.23%86.54M-28.70%77.41M104.21%53.82M25.31%150.68M21.73%127.69M13.67%108.57M-61.85%26.35M-78.96%120.25M
Earning per share
Basic earning per share 167.50%1.073.23%1.28-35.35%0.64-46.23%0.5753.85%0.45.08%1.24-3.88%0.9912.77%1.06-61.76%0.26-79.55%1.18
Diluted earning per share 167.50%1.073.23%1.28-35.35%0.64-46.23%0.5753.85%0.45.08%1.24-3.88%0.9912.77%1.06-61.76%0.26-79.55%1.18
Other composite income 63.23K-1.02M1.3M1.44M
Other composite income of parent company owners --63.23K---1.02M--1.3M--1.44M------------------------
Total composite income 171.56%146.15M14.76%172.92M-31.21%87.84M-27.37%78.85M104.21%53.82M25.40%150.68M21.83%127.69M13.78%108.57M-61.80%26.35M-78.99%120.16M
Total composite income of parent company owners 171.56%146.15M14.76%172.92M-31.21%87.84M-27.37%78.85M104.21%53.82M25.31%150.68M21.73%127.69M13.67%108.57M-61.85%26.35M-78.96%120.25M
Total composite income of minority owners ----------------------------99.64%-335.5399.66%-311.78-125.74%-92.32K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion----------------
Auditor --Daishin Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg